S-CD95L is increased in sera of human idiopathic pulmonary fibrosis (IPF) and bleomycin-induced lung fibrosis in mice and this ligand prevents the elimination of fibrotic-lung myofibroblasts by CD95L-expressing T cells (109). Here, FASLG is linked to idiopathic pulmonary fibrosis.